ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC30854-25mg |
|
346688-38-8 |
Pridopidine (ACR16)
|
0 | C15H23NO2S | |
GC30854-10mg |
|
346688-38-8 |
Pridopidine (ACR16)
|
0 | C15H23NO2S | |
GC30854-5mg |
|
346688-38-8 |
Pridopidine (ACR16)
|
0 | C15H23NO2S | |
GC30854-2mg |
|
346688-38-8 |
Pridopidine (ACR16)
|
0 | C15H23NO2S | |
GC30854-10mM(1mLinDMSO) |
|
346688-38-8 |
Pridopidine (ACR16)
|
0 | C15H23NO2S | |
GC30853-10mg |
|
133737-32-3 |
Pagoclone ((+)-RP-59037)
|
0 | C23H22ClN3O2 | |
GC30853-5mg |
|
133737-32-3 |
Pagoclone ((+)-RP-59037)
|
0 | C23H22ClN3O2 | |
GC30853-2mg |
|
133737-32-3 |
Pagoclone ((+)-RP-59037)
|
0 | C23H22ClN3O2 | |
GC30853-10mM(1mLinDMSO) |
|
133737-32-3 |
Pagoclone ((+)-RP-59037)
|
0 | C23H22ClN3O2 | |
GC30852-100mg |
|
1026791-61-6 |
Org-26576
|
0 | C11H12N2O2 | |
GC30852-50mg |
|
1026791-61-6 |
Org-26576
|
0 | C11H12N2O2 | |
GC30852-10mg |
|
1026791-61-6 |
Org-26576
|
0 | C11H12N2O2 | |
GC30852-5mg |
|
1026791-61-6 |
Org-26576
|
0 | C11H12N2O2 | |
GC30852-10mM(1mLinDMSO) |
|
1026791-61-6 |
Org-26576
|
0 | C11H12N2O2 | |
GC30851-100mg |
|
204512-90-3 |
Tecadenoson (CVT-510)
|
0 | C14H19N5O5 | |
GC30851-50mg |
|
204512-90-3 |
Tecadenoson (CVT-510)
|
0 | C14H19N5O5 | |
GC30851-25mg |
|
204512-90-3 |
Tecadenoson (CVT-510)
|
0 | C14H19N5O5 | |
GC30851-10mg |
|
204512-90-3 |
Tecadenoson (CVT-510)
|
0 | C14H19N5O5 | |
GC30851-5mg |
|
204512-90-3 |
Tecadenoson (CVT-510)
|
0 | C14H19N5O5 | |
GC30851-10mM(1mLinDMSO) |
|
204512-90-3 |
Tecadenoson (CVT-510)
|
0 | C14H19N5O5 | |